Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder.

Vagus nerve stimulation (VNS) shows a positive treatment effect and improved quality of life (QoL) among patients with ...

A single dose of psilocybin may offer relief for patients with severe treatment-resistant depression, according to an open-label study published in the American Journal of Psychiatry. The research, ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

A study shows elderly drivers with depression are prone to risky behaviors, highlighting the need for screenings and ...

Knowing how to transition from SSRIs to SNRIs will help you better control your symptoms and enhance the results of your ...

Antidepressants known as selective serotonin reuptake inhibitors, or SSRIs have been the first line of treatment for mood ...

The evolutionary perspective on depression suggest that depression may have healing value in its own right. Some ...

For nearly 20 years, antidepressants have carried suicide risk warnings for young people. Now, experts are questioning if the ...

The Food and Drug Administration has issued a recall on the antidepressant Duloxetine due to fears it could contain a known cancer-causing agent called N-nitroso-duloxetine. The drug’s ...

Human Rights Watch on Thursday condemned "atrocities" committed against civilians by Mali's army, the Russian mercenary group Wagner, and Islamist armed groups since UN peacekeepers withdrew a ...